299 related articles for article (PubMed ID: 28222069)
1. Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey.
Lehto US; Tenhola H; Taari K; Aromaa A
Br J Cancer; 2017 Mar; 116(7):864-873. PubMed ID: 28222069
[TBL] [Abstract][Full Text] [Related]
2. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
[TBL] [Abstract][Full Text] [Related]
3. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
4. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
[TBL] [Abstract][Full Text] [Related]
5. Quality of life and satisfaction with information after radical prostatectomy, radical external beam radiotherapy and postoperative radiotherapy: a long-term follow-up study.
Nicolaisen M; Müller S; Patel HR; Hanssen TA
J Clin Nurs; 2014 Dec; 23(23-24):3403-14. PubMed ID: 24890131
[TBL] [Abstract][Full Text] [Related]
6. Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
Hoffman KE; Penson DF; Zhao Z; Huang LC; Conwill R; Laviana AA; Joyce DD; Luckenbaugh AN; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Koyama T; Barocas DA
JAMA; 2020 Jan; 323(2):149-163. PubMed ID: 31935027
[TBL] [Abstract][Full Text] [Related]
7. Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer.
Chen RC; Basak R; Meyer AM; Kuo TM; Carpenter WR; Agans RP; Broughman JR; Reeve BB; Nielsen ME; Usinger DS; Spearman KC; Walden S; Kaleel D; Anderson M; Stürmer T; Godley PA
JAMA; 2017 Mar; 317(11):1141-1150. PubMed ID: 28324092
[TBL] [Abstract][Full Text] [Related]
8. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
[TBL] [Abstract][Full Text] [Related]
9. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
[TBL] [Abstract][Full Text] [Related]
10. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study.
Mazariego CG; Egger S; King MT; Juraskova I; Woo H; Berry M; Armstrong BK; Smith DP
BMJ; 2020 Oct; 371():m3503. PubMed ID: 33028540
[TBL] [Abstract][Full Text] [Related]
11. Functional Outcomes After Localized Prostate Cancer Treatment.
Al Hussein Al Awamlh B; Wallis CJD; Penson DF; Huang LC; Zhao Z; Conwill R; Talwar R; Morgans AK; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; O'Neil BB; Koyama T; Hoffman KE; Barocas DA
JAMA; 2024 Jan; 331(4):302-317. PubMed ID: 38261043
[TBL] [Abstract][Full Text] [Related]
12. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.
Sureda A; Fumadó L; Ferrer M; Garín O; Bonet X; Castells M; Mir MC; Abascal JM; Vigués F; Cecchini L; Suárez JF
Health Qual Life Outcomes; 2019 Jan; 17(1):11. PubMed ID: 30642340
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.
Wei JT; Dunn RL; Sandler HM; McLaughlin PW; Montie JE; Litwin MS; Nyquist L; Sanda MG
J Clin Oncol; 2002 Jan; 20(2):557-66. PubMed ID: 11786586
[TBL] [Abstract][Full Text] [Related]
15. Patient experiences at diagnosis and psychological well-being in prostate cancer: A Finnish national survey.
Lehto US; Helander S; Taari K; Aromaa A
Eur J Oncol Nurs; 2015 Jun; 19(3):220-9. PubMed ID: 25547457
[TBL] [Abstract][Full Text] [Related]
16. Patients' satisfaction with different modalities of prostate cancer therapy--a retrospective survey among 634 patients.
Wagner W; Bölling T; Hambruegge C; Hartlapp J; Krukemeyer MG
Anticancer Res; 2011 Nov; 31(11):3903-8. PubMed ID: 22110217
[TBL] [Abstract][Full Text] [Related]
17. [The accuracy of patients' perceptions of the risks associated with localised prostate cancer treatments].
van Stam MA; Aaronson NK; van der Poel HG; van der Voort van Zyp JRN; Tillier CN; Horenblas S; Bosch JLHR
Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040303
[TBL] [Abstract][Full Text] [Related]
18. Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.
Guedea F; Ferrer M; Pera J; Aguiló F; Boladeras A; Suárez JF; Cunillera O; Ferrer F; Pardo Y; Martínez E; Ventura M
Clin Transl Oncol; 2009 Jul; 11(7):470-8. PubMed ID: 19574206
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and satisfaction with outcome among prostate-cancer survivors.
Sanda MG; Dunn RL; Michalski J; Sandler HM; Northouse L; Hembroff L; Lin X; Greenfield TK; Litwin MS; Saigal CS; Mahadevan A; Klein E; Kibel A; Pisters LL; Kuban D; Kaplan I; Wood D; Ciezki J; Shah N; Wei JT
N Engl J Med; 2008 Mar; 358(12):1250-61. PubMed ID: 18354103
[TBL] [Abstract][Full Text] [Related]
20. Psychological and functional effect of different primary treatments for prostate cancer: A comparative prospective analysis.
Sciarra A; Gentilucci A; Salciccia S; Von Heland M; Ricciuti GP; Marzio V; Pierella F; Musio D; Tombolini V; Frantellizzi V; Pasquini M; Maraone A; Guandalini A; Maggi M
Urol Oncol; 2018 Jul; 36(7):340.e7-340.e21. PubMed ID: 29706458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
